Salazopyrin Tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

salazopyrin tafla 500 mg

pfizer aps - sulfasalazinum inn - tafla - 500 mg

Salazopyrin EN-tabs Magasýruþolin tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

salazopyrin en-tabs magasýruþolin tafla 500 mg

pfizer aps - sulfasalazinum inn - magasýruþolin tafla - 500 mg

Valaciclovir Bluefish Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

valaciclovir bluefish filmuhúðuð tafla 500 mg

bluefish pharmaceuticals ab - valaciclovirum hýdróklóríð - filmuhúðuð tafla - 500 mg

Valsartan/Hydrochlorothiazide Krka Filmuhúðuð tafla 160 mg/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan/hydrochlorothiazide krka filmuhúðuð tafla 160 mg/12,5 mg

krka sverige ab - hydrochlorothiazide; valsartanum inn - filmuhúðuð tafla - 160 mg/12,5 mg

Valsartan/Hydrochlorothiazide Krka Filmuhúðuð tafla 160 mg/25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan/hydrochlorothiazide krka filmuhúðuð tafla 160 mg/25 mg

krka sverige ab - hydrochlorothiazide; valsartanum inn - filmuhúðuð tafla - 160 mg/25 mg

Valsartan/Hydrochlorothiazide Krka Filmuhúðuð tafla 80 mg/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan/hydrochlorothiazide krka filmuhúðuð tafla 80 mg/12,5 mg

krka sverige ab - valsartanum inn; hydrochlorothiazide - filmuhúðuð tafla - 80 mg/12,5 mg

Valsartan/Hydroklortiazid Jubilant Filmuhúðuð tafla 160 mg/ 12.5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan/hydroklortiazid jubilant filmuhúðuð tafla 160 mg/ 12.5 mg

jubilant pharmaceuticals nv - valsartanum inn; hydrochlorothiazidum inn - filmuhúðuð tafla - 160 mg/ 12.5 mg

Sivextro Evrópusambandið - íslenska - EMA (European Medicines Agency)

sivextro

merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.

Tabrecta Evrópusambandið - íslenska - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Scemblix Evrópusambandið - íslenska - EMA (European Medicines Agency)

scemblix

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.